Lawrence Steinman - Net Worth and Insider Trading
Lawrence Steinman Net Worth
The estimated net worth of Lawrence Steinman is at least $2 Million dollars as of 2024-12-28. Lawrence Steinman is the Director of Neurocrine Biosciences Inc and owns about 15,500 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $2 Million. Lawrence Steinman is the Director of Pasithea Therapeutics Corp and owns about 66,359 shares of Pasithea Therapeutics Corp (KTTA) stock worth over $181,160. Lawrence Steinman is also the Director of BioAtla Inc and owns about 38,459 shares of BioAtla Inc (BCAB) stock worth over $24,537. Besides these, Lawrence Steinman also holds 180 Life Sciences Corp (ATNF) . Details can be seen in Lawrence Steinman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence Steinman has not made any transactions after 2023-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence Steinman
Lawrence Steinman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence Steinman owns 5 companies in total, including Atreca Inc (BCEL) , Neurocrine Biosciences Inc (NBIX) , and 180 Life Sciences Corp (ATNF) among others .
Click here to see the complete history of Lawrence Steinman’s form 4 insider trades.
Insider Ownership Summary of Lawrence Steinman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCEL | Atreca Inc | 2019-06-19 | director |
| NBIX | Neurocrine Biosciences Inc | 2005-03-02 | director |
| ATNF | 180 Life Sciences Corp | 2023-06-01 | director |
 | | 2023-12-19 | director |
| | 2023-06-02 | director |
Lawrence Steinman Latest Holdings Summary
Lawrence Steinman currently owns a total of 4 stocks. Among these stocks, Lawrence Steinman owns 15,500 shares of Neurocrine Biosciences Inc (NBIX) as of March 2, 2005, with a value of $2 Million and a weighting of 91.1%. Lawrence Steinman owns 66,359 shares of Pasithea Therapeutics Corp (KTTA) as of June 2, 2023, with a value of $181,160 and a weighting of 7.64%. Lawrence Steinman also owns 38,459 shares of BioAtla Inc (BCAB) as of December 19, 2023, with a value of $24,537 and a weighting of 1.03%. The other 1 stocks 180 Life Sciences Corp (ATNF) have a combined weighting of 0.23% among all his current holdings.
Latest Holdings of Lawrence Steinman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2005-03-02 | 15,500 | 139.44 | 2,161,320 |
| KTTA | Pasithea Therapeutics Corp | 2023-06-02 | 66,359 | 2.73 | 181,160 |
| BCAB | BioAtla Inc | 2023-12-19 | 38,459 | 0.64 | 24,537 |
| ATNF | 180 Life Sciences Corp | 2023-06-01 | 2,533 | 2.15 | 5,446 |
Holding Weightings of Lawrence Steinman
Lawrence Steinman Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence Steinman has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 4,000 shares on March 2, 2005, which brought Lawrence Steinman around $164,400.
According to the SEC Form 4 filings, Lawrence Steinman has made a total of 1 transactions in Pasithea Therapeutics Corp (KTTA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pasithea Therapeutics Corp is the acquisition of 1,500 shares on June 2, 2023, which cost Lawrence Steinman around $12,900.
According to the SEC Form 4 filings, Lawrence Steinman has made a total of 5 transactions in BioAtla Inc (BCAB) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in BioAtla Inc is the acquisition of 20,000 shares on December 19, 2023, which cost Lawrence Steinman around $41,000.
More details on Lawrence Steinman's insider transactions can be found in the Insider Trading History of Lawrence Steinman table.Insider Trading History of Lawrence Steinman
- 1
Lawrence Steinman Trading Performance
GuruFocus tracks the stock performance after each of Lawrence Steinman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lawrence Steinman is 1.74%. GuruFocus also compares Lawrence Steinman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lawrence Steinman within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lawrence Steinman's insider trading performs compared to the benchmark.
Performance of Lawrence Steinman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.64 | | | | | |
| Relative Return to S&P 500(%) | -2.12 | | | | | |
Lawrence Steinman Ownership Network
Lawrence Steinman Owned Company Details
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Lawrence Steinman is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc (BCEL) Insider Trades Summary
Over the past 18 months, Lawrence Steinman made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
Lawrence Steinman Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence Steinman. You might contact Lawrence Steinman via mailing address: 10555 Science Center Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
